Amneal Pharmaceuticals, Inc. AMRX Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Amneal Pharmaceuticals, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s current ratio?
- Amneal Pharmaceuticals, Inc. (AMRX) reported current ratio of 2.5× in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s current ratio changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s current ratio increased by 75.9% year-over-year, from 1.4× to 2.5×.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s current ratio?
- Over 5 years (2020 to 2025), Amneal Pharmaceuticals, Inc.'s current ratio has grown at a -1.1% compound annual growth rate (CAGR), from 2.3× to 2.2×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.